Global Immunoassay Market Outlook to 2023: Technological Advancements and the Rise in Prevalence of Chronic & Infectious Diseases are Driving Growth

DUBLIN–(BUSINESS WIRE)–The “Global
Immunoassay Market – Forecasts from 2018 to 2023”
report has
been added to ResearchAndMarkets.com’s offering.

Segmentation

By Technology

  • Radioimmunoassay (RIA)
  • Counting Immunoassay (CIA)
  • Enzyme Immunoassays (EIA) or Enzyme-linked Immunosorbent Assays (ELISA)
  • Fluoroimmnoassay (FIA)
  • Chemiluminescence Immunoassay (CLIA)

By Therapeutic Area

  • Infectious Diseases
  • Bone Metabolism
  • Immunology
  • Neurobiology
  • Others

By End-User Industry

  • Hospitals and Clinics
  • Diagnostics
  • Pharmaceutical and Biotechnology Companies
  • Research Academic Laboratories

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Immunoassay Market Forecast by Technique

6. Global Immunoassay Market Forecast by Therapeutic Area

7. Global Immunoassay Market Forecast by End-User

8. Global Immunoassay Market Forecast by Geography

9. Competitive Intelligence

10. Company Profiles

  • Fujirebio
  • Quidel Corporation
  • Roche Diagnostics
  • Immunodiagnostic Systems
  • Arbor Assays
  • Omega Diagnostics Group PLC
  • Beckman Coulter, Inc.
  • ImmunoReagents, Inc.
  • Aushon BioSystems
  • Mercodia AB

For more information about this report visit https://www.researchandmarkets.com/research/6q7vcz/global?w=4

الموقع يستعمل RSS Poster بدعم القاهرة اليوم